Related by context. All words. (Click for frequent words.) 75 monoclonal gammopathy 74 ADPKD 73 renal cell carcinomas 73 nonmelanoma skin cancers 72 basal cell nevus syndrome 71 prostate cancer CaP 71 mesotheliomas 71 gastric adenocarcinoma 71 neoplasias 71 HNSCC 70 familial pancreatic cancer 70 germline mutations 70 neoplastic 70 epithelial tumors 70 TNF blocker therapy 70 carcinoid 70 IgA deficiency 70 thymoma 70 atypical hyperplasia 69 sCJD 69 K ras mutations 69 endometrial hyperplasia 69 PTPN# 69 histological subtype 69 mycosis fungoides 69 node metastases 69 basal cell carcinoma BCC 69 colorectal adenoma 69 HER2 overexpression 69 advanced adenoma 69 malignant neoplasm 69 idiopathic PAH 69 serous ovarian cancer 69 hepatocellular carcinomas 69 etiologic 69 carcinoid tumors 69 BCR ABL mutations 69 GBM tumors 69 KRAS oncogene 69 untreated celiac disease 68 leukaemias 68 histologic subtype 68 PCNSL 68 lymphocytic 68 squamous cell lung cancer 68 pathophysiologic 68 nonmelanoma skin cancer 68 Hashimoto thyroiditis 68 clinicopathological 68 myeloproliferative diseases 68 seminomas 68 bladder carcinoma 68 lobular carcinoma 68 clinically detectable 68 SSc 68 advanced adenomas 68 nonmelanoma 68 carcinoid tumor 68 chromosomal rearrangement 68 Epstein Barr virus EBV 68 leiomyomas 68 Hurthle cell 68 Gorlin syndrome 68 neoplasm 68 adenomatous polyps 68 Chlamydia pneumoniae 68 familial ALS 68 precursor lesions 68 APOL1 68 acute leukemias 68 allogeneic HSCT 68 NMIBC 68 invasive fungal infection 68 malignant pleural mesothelioma 68 Chronic pancreatitis 68 PCa 68 colorectal carcinoma 68 lung adenocarcinomas 67 T1DM 67 MYCN amplification 67 familial aggregation 67 haematologic 67 cranial irradiation 67 pancreatic adenocarcinoma 67 GISTs 67 NNRTI resistance 67 micrometastases 67 glomerulonephritis 67 paragangliomas 67 astrocytomas 67 dysglycemia 67 essential thrombocythemia 67 basal cell carcinomas 67 oesophageal adenocarcinoma 67 myeloproliferative 67 chlamydial infection 67 subclinical 67 hematopoietic cancers 67 Acute myeloid leukemia 67 LVNC 67 genetic polymorphisms 67 urothelial carcinoma 67 EBV infection 67 eosinophilic 67 susceptibility loci 67 nonalcoholic steatohepatitis NASH 67 mitochondrial toxicity 67 proliferative diabetic retinopathy 67 osteosarcomas 67 aminotransferases 67 differentiated thyroid 67 myeloproliferative neoplasms 67 lichen planus 67 androgen deficiency 67 brain lesions 67 ALT flares 67 bacteriuria 67 Sjögren syndrome 67 testicular germ cell 67 esophageal squamous cell carcinoma 67 IPAH 67 paraganglioma 67 CP CPPS 67 leukoencephalopathy 67 testicular tumors 67 GBA mutations 67 nonhereditary 67 mucinous 67 atrophic gastritis 67 MGd 67 invasive carcinoma 67 papillary carcinoma 67 NOMID 66 orchitis 66 cryptogenic 66 systemic amyloidosis 66 liver transplant recipients 66 hereditary predisposition 66 thyrotoxicosis 66 Postoperative complications 66 Chronic lymphocytic leukemia 66 gene rearrangements 66 thyroid nodules 66 Cholangiocarcinoma 66 hamartomas 66 LV dysfunction 66 elevated triglyceride levels 66 neoplasms 66 subclinical hyperthyroidism 66 smoldering myeloma 66 Recurrences 66 TEAEs 66 antiphospholipid antibodies 66 nodal metastasis 66 EXJADE 66 Leukemias 66 progressive neurodegenerative disorder 66 intestinal metaplasia 66 EoE 66 relapsed MM 66 pheochromocytoma 66 skeletal metastases 66 Cryptococcus neoformans 66 pituitary adenomas 66 neoplastic lesions 66 premalignant lesions 66 diabetic kidney 66 pre malignant lesions 66 SLNB 66 chronic hepatitis cirrhosis 66 nonalcoholic steatohepatitis 66 neurologic complications 66 lymphoproliferative disorders 66 paraneoplastic 66 herpesviruses 66 infarcts 66 Papillary 66 candidemia 66 interstitial pneumonia 66 molecular subtypes 66 pulmonary metastases 66 colorectal cancer CRC 66 HGPIN 66 HSV1 66 EGFR mutations 66 hyperplastic 66 prostate adenocarcinoma 66 Leydig cell 66 IL 1ß 66 latent celiac disease 66 Candida infection 66 missense mutations 66 varicella infection 66 myelodysplasia 66 intravenous bisphosphonates 66 genetic loci 66 hepatic failure 66 adenomatous 66 JAK2 mutation 66 leukemia AML 66 carotid stenosis 66 lipid abnormalities 66 APOE ε4 66 seropositivity 66 malignant lymphoma 66 neuroblastomas 66 HBeAg negative 66 hematologic toxicity 66 coronary artery aneurysms 66 neuroblastoma tumors 66 GIST tumors 66 XMRV infection 66 sarcomatoid 66 pericardial effusion 66 Clusterin 66 PTLD 66 bladder cancers 66 breast carcinomas 66 medullary thyroid cancer 66 CC genotype 65 colorectal adenomas 65 pharmacokinetic interactions 65 LHRH agonists 65 thiopurine 65 SNP rs# [001] 65 underlying pathophysiology 65 SE alleles 65 TT genotype 65 familial clustering 65 PsA 65 BRAF mutations 65 ABCB1 65 incidentalomas 65 C. trachomatis 65 atherothrombotic disease 65 inherited mutations 65 ARVD 65 cerebral microbleeds 65 squamous cell carcinoma SCC 65 chronic GVHD 65 anti JCV antibodies 65 gene polymorphisms 65 histologically 65 parkinsonism 65 metastatic neuroendocrine tumors 65 MYH9 gene 65 HLA DRB1 * 65 neuroendocrine cancers 65 obstructive coronary artery 65 oropharyngeal cancer 65 adenocarcinomas 65 mutated KRAS 65 microbleeds 65 clinicopathologic 65 etiologic agent 65 recurrent glioblastoma multiforme 65 polyposis 65 GSTT1 65 carcinoids 65 metachronous 65 PTEN mutations 65 biochemical abnormalities 65 elevated CRP 65 HCV infection 65 Trichomonas vaginalis 65 QTc prolongation 65 neurocognitive impairment 65 diabetes mellitus DM 65 neurofibromas 65 JAK mutations 65 Polycythemia vera 65 distinct subtypes 65 LRRK2 mutations 65 noncardiac 65 hypermethylated 65 sporadic ALS 65 systolic dysfunction 65 TP# mutations 65 SGPT 65 comorbid depression 65 LQTS 65 metastatic lesions 65 renal cysts 65 microsatellite instability 65 hypovitaminosis D 65 neurologic symptoms 65 JMML 65 pyelonephritis 65 breast carcinoma 65 de novo mutations 65 NP CRNs 65 aetiological 65 invasive carcinomas 65 prostate carcinoma 65 malignant lymphomas 65 β blockers 65 pleural mesothelioma 65 unknown etiology 65 malignant lesions 65 overt hypothyroidism 65 CIN2 + 65 severe hypersensitivity reactions 65 Prostatitis 65 Squamous 65 mediastinitis 65 benign polyps 65 chorioamnionitis 65 primary hyperparathyroidism 65 invasive aspergillosis 65 BRAF gene 65 mucosal lesions 65 H pylori 65 bronchogenic carcinoma 65 IDH1 mutation 65 endometrial carcinoma 65 CYT# potent vascular disrupting 65 HNPCC 65 papillary renal cell carcinoma 65 BRAF V#E 65 genotypic resistance 65 myelofibrosis polycythemia vera 65 APOE e4 65 carotid plaques 65 pilocytic astrocytomas 65 metastatic lung cancer 65 KRAS mutations 65 HER2 expression 65 GSTP1 65 Pneumocystis carinii pneumonia 65 metaplasia 65 necrotizing 65 autosomal dominant disorder 65 vWD 65 Malignant mesothelioma 65 adenoma 65 Diabetic nephropathy 65 juvenile idiopathic arthritis JIA 65 bullous 65 macroalbuminuria 65 invasive ductal 65 Adenomas 65 immunodeficiency 65 BRAF mutation 65 situ LCIS 65 malignancies 65 distant metastasis 65 tumor histology 65 B7 H3 65 HIV HCV coinfected 65 CYP #A# 65 microdeletions 65 narcolepsy cataplexy 65 immunocompetent 65 intracranial hemorrhage ICH 65 WNK1 65 colorectal liver metastases 64 TGFBR1 * 6A 64 acute aortic dissection 64 inherited predisposition 64 Relapsing remitting MS 64 hyperacute 64 lung metastasis 64 #F FDG PET 64 amenorrhoea 64 genetic variants associated 64 curative resection 64 colorectal tumors 64 hyperhomocysteinemia 64 Estrogen Receptor 64 nephrogenic fibrosing dermopathy 64 atypia 64 urothelial cancer 64 coronary calcification 64 neoplastic cells 64 subclinical atherosclerosis 64 hypercalcemia 64 superinfection 64 HLA DRB1 64 imatinib resistance 64 alcoholic hepatitis 64 Bacterial vaginosis 64 autonomic dysfunction 64 AA Amyloidosis 64 cutaneous melanoma 64 etiologies 64 angiographically 64 TMPRSS2 ERG fusion 64 Torsades de Pointes 64 supratentorial 64 cytogenetic abnormalities 64 pCR 64 KRAS status 64 Cognitive impairment 64 Thyroid nodules 64 Eisenmenger syndrome 64 hyperparathyroidism 64 aminotransferase levels 64 Adenocarcinoma 64 cisplatin resistant 64 gastric carcinoma 64 adrenalectomy 64 anterior uveitis 64 familial adenomatous polyposis 64 premalignant 64 univariate analyzes 64 granulomatous 64 CTEPH 64 gallstone disease 64 torsade de pointes 64 Genetic variants 64 pT2 64 trans retinoic acid 64 biochemical recurrence 64 coinfection 64 malignant transformation 64 rebleeding 64 p# mutations 64 Kaposi sarcoma 64 Diabetic neuropathy 64 nonmalignant 64 Medullary thyroid cancer 64 autoimmune thyroid 64 mtDNA mutations 64 gastrointestinal stromal tumors GISTs 64 euthymic patients 64 bronchopulmonary dysplasia 64 arterial calcification 64 NRTI resistance 64 atypical hemolytic uremic syndrome 64 POAG 64 airway hyperresponsiveness 64 hypoperfusion 64 basal cell cancers 64 renal carcinoma 64 TCF#L# gene 64 calculi 64 colorectal polyps 64 GPC5 64 CIN3 + 64 Wegener granulomatosis 64 hemorrhagic complications 64 chromosome #p#.# 64 S aureus 64 immunodeficiencies 64 Brain metastases 64 thyrotropin levels 64 NAFLD 64 HLA B# 64 hepatic cirrhosis 64 LRAT 64 systemic scleroderma 64 demyelinating 64 hyperprolactinemia 64 cholangiocarcinoma 64 cystic fibrosis chronic pancreatitis 64 myeloproliferative disorders 64 thrombocytopenic 64 Heavy menstrual bleeding 64 Adjuvant chemotherapy 64 S. aureus isolates 64 neurological manifestations 64 pleomorphic 64 JAK2 enzyme 64 gonococcal 64 seminoma 64 bacteraemia 64 ductal breast cancer 64 p# activation 64 invasive lobular 64 sporadic Creutzfeldt Jakob 64 prognostic significance 64 Genetic predisposition 64 neuropsychiatric symptoms 64 BRCA1 mutations 64 abacavir Ziagen 64 CIN3 64 #q#.# [001] 64 Microalbuminuria 64 GNAQ 64 renal tumors 64 prolonged QT interval 64 myopathies 64 malignant polyps 64 modifier genes 64 dopaminergic therapy 64 Inflammatory bowel diseases 64 T2DM 64 histopathologic examination 64 IGFD 64 monogenic 64 follicular thyroid cancer 64 K#R [002] 64 cerebral vasospasm 64 lymphocytic leukemia 64 follicular adenoma 64 metastatic bladder 64 choroidal neovascularization 64 rs# [004] 64 nucleoside analogues 64 liver metastasis 63 HBeAg 63 hypercoagulable 63 Autoimmune disorders 63 INCB# [003] 63 invasive ductal breast cancer 63 epithelioid 63 lymph node metastases 63 Barrett esophagus BE 63 ductal cancer 63 androgen deprivation 63 neuropathologic 63 generalized vitiligo 63 hypermethylation 63 autoimmune pancreatitis 63 Hepatotoxicity 63 histologically confirmed 63 G6PD deficiency 63 histologic subtypes 63 nonischemic 63 Aortic stenosis 63 histopathological 63 leukemia ALL 63 hypercalciuria 63 plasminogen activators 63 locoregional recurrence 63 Symadex 63 primary biliary cirrhosis 63 atherothrombosis 63 extramedullary 63 PARP inhibition 63 thromboembolism 63 nonmetastatic 63 mammographically 63 squamous cell cancers 63 cervical carcinoma 63 pernicious anemia 63 ALK mutations 63 monozygotic twin 63 thyroiditis 63 thromboembolic disease 63 Thrombocytopenia 63 stress cardiomyopathy 63 leiomyoma 63 extrapyramidal symptoms 63 bronchoalveolar 63 Sezary syndrome 63 FLT3 63 radiographic findings 63 clinico pathological 63 Asymptomatic 63 colorectal adenocarcinoma 63 lymphadenopathy 63 gross hematuria 63 chromosomal instability 63 nutlin 3a 63 recurrent VTE 63 Atypical Hemolytic Uremic Syndrome 63 colorectal polyp 63 Gliomas 63 carcinoembryonic antigen 63 Chronic Lymphocytic Leukemia CLL 63 thalidomide Thalomid 63 hepatocellular carcinoma HCC 63 biochemical relapse 63 ECG abnormalities 63 anemias 63 colorectal neoplasms 63 TNF α 63 UGT#A# * 63 coinfected patients 63 TTR gene 63 PAOD 63 systemic lupus erythematosus SLE 63 heterozygotes 63 Endometrial cancer 63 oncogenic HPV types 63 endometrial cancers 63 ductal carcinomas 63 antiphospholipid syndrome 63 PNH patients 63 Nicotine dependence 63 colorectal neoplasia 63 subclinical hypothyroidism 63 infective endocarditis 63 LTBI 63 motor neuron degeneration 63 missense mutation 63 FluCAM arm 63 Anaplastic 63 cystic lesions 63 salmeterol HFA MDI 63 penetrance 63 urethritis 63 lung cancer NSCLC 63 HBV infection 63 TTR amyloidosis 63 chronic HBV infection 63 neoplasia 63 Basal cell 63 lupus anticoagulant 63 genetic alterations 63 clinically insignificant 63 lupus scleroderma 63 onset diabetes mellitus 63 CVD mortality 63 lacunar 63 elevated LDH 63 olfactory dysfunction 63 ductal adenocarcinoma 63 efalizumab 63 prognostic indicator 63 Hepatocellular Carcinoma HCC 63 precancerous cervical lesions 63 NKX2 63 cervical lesions 63 Subgroup analyzes 63 cerebral infarction 63 angiosarcoma 63 cTnT 63 aneuploidies 63 cholelithiasis 63 GSTM1 gene 63 antidiabetic medication 63 metastatic malignant 63 thyroid dysfunction 63 rs# [002] 63 allogeneic bone marrow 63 nonseminoma 63 CIMZIA ™ 63 congenital anomalies 63 FTLD 63 Carcinoid tumors 63 pulmonary hypertension PH 63 breast cancer susceptibility genes 63 CMV infection 63 NAbs 63 malignant prostate 63 LRP5 63 PTEN gene 63 C. pneumoniae 63 thromboembolic 63 shorter telomere length 63 E. faecalis 63 intensive statin therapy 63 Glioma 63 fulminant hepatic failure 63 cirrhosis liver failure 63 hemolytic anemia 63 TACI mutations 63 uveal melanoma 63 herpes zoster shingles 63 thrombophilia 63 vivax 63 NOD mice 63 APOE genotype 63 glutamic acid decarboxylase 63 KCNH2 63 prostatic hyperplasia 63 bone marrow suppression 63 idiopathic pulmonary 63 fluconazole resistant 63 hemorrhagic cystitis 63 cytopathic 63 CYP #D# 63 TIMP 63 nondiabetic patients 63 retrospective cohort 63 Acute pancreatitis 63 ASCUS 63 mitochondrial dysfunction 63 hepatoma 63 2 diabetes T2D 63 metastatic RCC 63 transfusion syndrome 63 atopic 63 macrovascular events 63 hyperalgesia 63 Trichophyton rubrum 63 troponin T 63 promoter methylation 63 epigenetic alterations 63 EGFR inhibitors 63 teratogens 63 left ventricular dysfunction 63 MYH9 63 HBV genotype 63 predisposing factor 63 Candida species 63 cutaneous squamous cell carcinoma 63 Brugada Syndrome 63 serum calcium 63 mitochondrial metabolism 63 atypical ductal hyperplasia 63 liver scarring 63 pancytopenia 63 lymph node involvement 63 bullous pemphigoid 63 ataxias 63 FGFR2 63 A. fumigatus 63 gliosis 63 inducible nitric oxide synthase 63 beta carotene supplementation 63 nonsmall cell lung cancer 63 psychiatric comorbidities 63 dysthymic disorder 63 breast cancer subtypes 63 TNFalpha 63 medulloblastomas 63 Stent thrombosis 63 LRRK2 gene 63 nephrotoxicity 63 imatinib therapy 63 amyloid deposits 63 distant metastases 63 perioperative complications 63 lysosomal storage diseases 63 hepatic enzymes 63 Brugada syndrome 63 fluoroquinolone resistance 63 Malignant glioma 63 somatic mutations 63 enteroviral 63 malignant neoplasms 63 Waldenstrom macroglobulinemia 63 Glioblastoma Multiforme 63 thromboembolic complications 63 lysosomal storage disease 63 breast endometrial 63 histologies 63 Vitamin B# deficiency 63 latent tuberculosis infection 63 Immunohistochemical analysis 63 melanocytic nevi 63 neuritic 63 ocular toxicity 63 polycythemia vera PV 63 p# mutation 63 colorectal carcinomas 63 proximal colon 63 genetic syndromes 63 recurrent acute pancreatitis 62 hormone receptor negative 62 etiological 62 myocardial infarctions 62 ccRCC 62 cardiac troponin 62 Severe Primary IGFD 62 RET PTC rearrangements 62 enterovirus infection 62 unprovoked seizures 62 CHD7 62 prostate cancer PCa 62 small lymphocytic lymphoma 62 psychiatric comorbidity 62 parthenolide 62 relapsing remitting 62 multivariate adjustment 62 HER2 amplification 62 plasma pharmacokinetics 62 MLL2 62 hypopituitarism 62 Prehypertension 62 MLH1 62 metastatic malignant melanoma 62 pathologic diagnosis 62 molecular abnormalities 62 HSCT 62 Hypotension 62 Parkinson Disease PD 62 MTHFR 62 cancerous enlargement 62 poorer prognosis 62 HG PIN 62 QT prolongation 62 ximelagatran 62 BRAF V#E mutation 62 ERK signaling 62 hyperkalemia 62 human herpesvirus 62 CYP#D# gene 62 epididymitis 62 ischemic lesions 62 clinically meaningful differences 62 BRCA1 mutation carriers 62 Wwox 62 de ath 62 interstitial pneumonitis 62 bleomycin 62 renal dysfunction 62 postoperative complication 62 chronic urticaria 62 spinocerebellar ataxia 62 genomic alterations 62 nucleotide substitutions 62 IL#R 62 normal karyotype 62 mosaicism 62 alanine aminotransferase ALT 62 tryptase 62 tumoral 62 decompensated cirrhosis 62 ovarian carcinoma 62 mutated K ras 62 chromosomal aberrations 62 susceptible isolates 62 malignant pleural effusion 62 proliferative retinopathy 62 myeloproliferative disorder 62 Myelodysplastic syndromes MDS 62 EGFR mutation 62 FGFR2 gene 62 Gastric cancer 62 lignan intake 62 HbF 62 gefitinib Iressa 62 polymorphic ventricular tachycardia 62 thyroid carcinoma 62 arterial thickening 62 esophagitis 62 bronchopulmonary dysplasia BPD 62 hypophosphatemia 62 Helicobacter pylori infection 62 precancerous cervical 62 polypoid lesions 62 Genetic variation 62 aetiology 62 MALT lymphoma 62 autoantibodies 62 paroxysmal nocturnal hemoglobinuria 62 hereditary hemochromatosis 62 N. gonorrhoeae 62 azoospermia 62 parathyroid 62 locoregional 62 APTIVUS r 62 metastatic gastric 62 affective psychoses 62 #q# deletion 62 T2D 62 Doxil ® 62 Venous thromboembolism 62 eotaxin 62 T1c 62 lymphoma subtypes 62 radioiodine therapy 62 amyloid deposition 62 aberrant methylation 62 pretransplant 62 Metastases 62 perfusion abnormalities 62 tigecycline 62 eosinophilic pneumonia 62 typical antipsychotics 62 Haptoglobin 62 prognostic markers 62 Bcr Abl mutations 62 serum phosphate 62 prognostic marker 62 osteochondromas 62 hepatic fibrosis 62 haematopoietic 62 cytogenetic responses 62 Alzheimer Disease AD 62 acute myelogenous leukemia AML 62 candidiasis 62 rheumatologic 62 nephrogenic 62 pulmonary toxicity 62 estrogen receptor negative 62 benign breast 62 heavily pretreated 62 ADAMTS# 62 Opportunistic infections 62 somatic mutation 62 primary aldosteronism 62 allograft rejection 62 glioblastoma tumors 62 vestibular schwannomas 62 lobular cancer 62 intestinal polyps 62 Major depressive disorder 62 nodular melanoma 62 inflammatory rheumatic 62 Fas ligand 62 prostate carcinogenesis 62 meningiomas 62 epithelial barrier 62 AAT deficiency 62 IGFBP 62 Irritable bowel syndrome 62 solar keratosis 62 familial hypercholesterolemia 62 perineural invasion 62 renal allograft 62 hepatorenal syndrome 62 posaconazole 62 Cathepsin B 62 ALCL 62 chronic granulomatous disease 62 malignancy 62 Cardiotoxicity 62 AML MDS 62 trastuzumab Herceptin ® 62 grade gliomas 62 liver metastases 62 myeloproliferative neoplasms MPNs 62 cortical dysplasia 62 lactate dehydrogenase 62 stage IIIB 62 CDH1 62 Acute Myeloid Leukaemia AML 62 Hematologic 62 TPMT 62 autoimmune hemolytic anemia 62 thrombocytosis 62 oral Hycamtin 62 lipid lowering medications 62 renal fibrosis 62 syndromal 62 medically inoperable 62 Plasmodium vivax 62 TNF antagonist 62 Aspergillus species 62 susceptibility gene 62 rhinosinusitis 62 oligodendrogliomas 62 hypertrophic scars 62 lung adenocarcinoma 62 MELAS 62 pDCs 62 progressive neurodegenerative 62 atopic sensitization 62 stratifying patients 62 cytopenias 62 Uterine cancer 62 ERalpha 62 enterocolitis 62 cardioembolic stroke 62 thromboembolic events 62 DFMO 62 gene APOE4 62 MRSA isolates 62 genetic determinants 62 HER2 positive cancers 62 NKG2D 62 Basal cell carcinoma 62 tumor recurrence 62 C1 INH deficiency 62 MeCP2 gene 62 ERBB2 62 retinal vein occlusion 62 antiproliferative effects 62 alkylating agent 62 MSH2 62 pelvic lymphadenectomy 62 grade cervical intraepithelial 62 antigen PSA 62 riociguat 62 nonvascular 62 Kaplan Meier curve 62 microdeletion 62 Actinic Keratosis 62 sustained ventricular tachycardia 62 gene polymorphism 62 hyperammonemia 62 pheochromocytomas 62 Pseudomonas aeruginosa infections 62 teratoma 62 IKZF1 62 Legg Calvé Perthes disease 62 genomic variants 62 VUR 62 HepG2 cells 62 polyp recurrence 62 chromosomal alterations 62 hypoglycemic episodes 62 erythropoietic 62 serum urate levels 62 genital tract infections 62 neuropsychiatric disorders 62 infectious mononucleosis 62 cyclin E 62 pathological hallmark 62 Basal Cell 62 chronicity 62 Nonalcoholic fatty liver 62 somatization disorder 62 postoperative delirium 62 TIMP 1 62 haemolysis 62 genetic aberrations 62 urine cytology 62 benign prostatic hypertrophy BPH 62 LRP6 62 NAT2 62 esophagogastric junction 62 childhood leukemias 62 cardiac dysfunction